Acquisition - Fair value of assets acquired and liabilities assumed (Details) - USD ($) $ in Thousands |
6 Months Ended | |
|---|---|---|
Jun. 15, 2021 |
Jun. 30, 2021 |
|
| Fair values of the assets acquired and liabilities assumed | ||
| Total purchase price, net of cash acquired | $ 25,355 | |
| Obalon Therapeutics Inc. | ||
| Fair values of the assets acquired and liabilities assumed | ||
| Current assets | $ 5,887 | |
| Property and equipment, net | 796 | |
| Right-of-use assets | 335 | |
| Other assets | 1,898 | |
| Goodwill | 21,566 | |
| Developed technology | 2,730 | |
| Liabilities assumed | (2,650) | |
| Total purchase price | 30,562 | |
| Less: cash acquired | (5,207) | |
| Total purchase price, net of cash acquired | $ 25,355 |
| X | ||||||||||
- Definition The amount of Right-of-use assets recognized as of the acquisition date. No definition available.
|
| X | ||||||||||
- Definition Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|